Cohlhepp Ryan

Track

Insider profile

Cohlhepp Ryan's trades of Bicara Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-18 2026-05-15
PlS Planned sale
56,090 +19.1%
226.73
US$1,867,221 		56,090 +19.1% 226.73 US$1,867,221
2026-05-18 2026-05-15
PlS Planned sale
81,767 +39.1%
230.26
US$2,111,336 		81,767 +39.1% 230.26 US$2,111,336
2026-05-15 2026-05-15
PrS Proposed sale
52,274
39.04
US$3,370,143 		52,274 39.04 US$3,370,143
2026-04-17 2026-04-15
PlS Planned sale
4,500 -2.2%
23.01
US$103,533 		4,500 -2.2% 23.01 US$103,533
2026-04-17 2026-04-15
PlS Planned sale
8,000 -3.8%
23.01
US$184,058 		8,000 -3.8% 23.01 US$184,058
2026-04-15 2026-04-15
PrS Proposed sale
12,500
22.98
US$287,250 		12,500 22.98 US$287,250
2026-03-17 2026-03-16
PlS Planned sale
4,500 -2.2%
19.66
US$88,457 		4,500 -2.2% 19.66 US$88,457
2026-03-17 2026-03-16
PlS Planned sale
8,000 -3.8%
19.66
US$157,257 		8,000 -3.8% 19.66 US$157,257
2026-03-16 2026-03-16
PrS Proposed sale
12,500
19.34
US$241,750 		12,500 19.34 US$241,750
2026-03-05 2026-03-03
PlS Planned sale
4,500 -2.1%
18.16
US$81,734 		4,500 -2.1% 18.16 US$81,734
2026-03-05 2026-03-03
PlS Planned sale
12,892 -5.8%
18.16
US$234,159 		12,892 -5.8% 18.16 US$234,159
2026-03-03 2026-03-03
PrS Proposed sale
17,392
18.16
US$315,893 		17,392 18.16 US$315,893
2026-02-27 2026-02-25
PlS Planned sale
523 -0.2%
18.04
US$9,435 		523 -0.2% 18.04 US$9,435
2026-02-27 2026-02-25
PlS Planned sale
3,108 -1.5%
18.04
US$56,067 		3,108 -1.5% 18.04 US$56,067
2026-02-25 2026-02-25
PrS Proposed sale
3,631
18.04
US$65,501 		3,631 18.04 US$65,501
2026-01-26 2026-01-22
PlS Planned sale
3,828 -1.8%
18.10
US$69,296 		3,828 -1.8% 18.10 US$69,296
2026-01-22 2026-01-22
PrS Proposed sale
3,828
16.97
US$64,961 		3,828 16.97 US$64,961
2026-01-20 2026-01-15
PlS Planned sale
149 -0.1%
18.02
US$2,685 		149 -0.1% 18.02 US$2,685
2026-01-15 2026-01-15
PrS Proposed sale
149
18.02
US$2,685 		149 18.02 US$2,685
2025-12-16 2025-12-15
PlS Planned sale
4,500 -2.3%
18.68
US$84,077 		4,500 -2.3% 18.68 US$84,077
2025-12-16 2025-12-15
PlS Planned sale
8,000 -4.0%
18.68
US$149,470 		8,000 -4.0% 18.68 US$149,470
2025-12-15 2025-12-15
PrS Proposed sale
12,500
18.70
US$233,750 		12,500 18.70 US$233,750
2025-11-25 2025-11-21
PlS Planned sale
4,500 -2.3%
18.05
US$81,212 		4,500 -2.3% 18.05 US$81,212
2025-11-25 2025-11-21
PlS Planned sale
8,000 -3.9%
18.05
US$144,376 		8,000 -3.9% 18.05 US$144,376
2025-11-21 2025-11-21
PrS Proposed sale
12,500
18.05
US$225,588 		12,500 18.05 US$225,588
2025-10-16 2025-10-15
PlS Planned sale
4,500 -2.2%
18.16
US$81,699 		4,500 -2.2% 18.16 US$81,699
2025-10-16 2025-10-15
PlS Planned sale
8,000 -3.8%
18.16
US$145,243 		8,000 -3.8% 18.16 US$145,243
2025-10-15 2025-10-15
PrS Proposed sale
12,500
18.13
US$226,601 		12,500 18.13 US$226,601
2025-10-08 2025-10-07
PlS Planned sale
2,900 -1.4%
18.06
US$52,371 		2,900 -1.4% 18.06 US$52,371
2025-10-08 2025-10-07
PlS Planned sale
8,000 -3.7%
18.06
US$144,473 		8,000 -3.7% 18.06 US$144,473
2025-10-07 2025-10-07
PrS Proposed sale
10,900
18.00
US$196,200 		10,900 18.00 US$196,200
2025-10-08 2025-10-06
PlS Planned sale
15,600 -7.1%
18.06
US$281,666 		15,600 -7.1% 18.06 US$281,666
2025-10-08 2025-10-06
PlS Planned sale
24,000 -9.8%
18.06
US$433,332 		24,000 -9.8% 18.06 US$433,332
2025-10-06 2025-10-06
PrS Proposed sale
39,600
18.06
US$714,997 		39,600 18.06 US$714,997